Fenwick Represents Johnson & Johnson Innovation in Paige’s Series C Financing

Fenwick represented Johnson & Johnson Innovation (JJDC, Inc.), the strategic venture capital arm of Johnson & Johnson, as a co-lead investor in a Series C financing round for Paige, a global leader in AI-based diagnostic software in pathology.

JJDC was joined by Casdin Capital in January and by KKR in March as co-lead investors, bringing the round to more than $125 million. Additional investors include Catalio Capital Management, existing investors and other funds. More information can be obtained from the company’s January announcement and March announcement.

The Fenwick transaction team included corporate partner Ian Goldstein and associate Andrew Murphy and intellectual property partner Stuart Meyer and associate Jennifer Yoon.